Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients

被引：23

作者：

Fytili, P

Ciesek, S

Manns, MP

Wedemeyer, H

Neipp, M

Helfritz, F

Klempnauer, J

Bara, C

Haverich, A

机构：

[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany

[2] Hannover Med Sch, Dept Visceral & Transplant Surg, D-30625 Hannover, Germany

[3] Hannover Med Sch, Dept Heart Thorac Surg, D-30625 Hannover, Germany

来源：

TRANSPLANTATION | 2006年 / 81卷 / 05期

关键词：

D O I：

10.1097/01.tp.0000198585.51562.57

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：808 / 809

页数：2

共 3 条

[1]

Fabrizi F, 2002, J NEPHROL, V15, P605

[2] Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation [J].

Hartwig, MG ;

Patel, V ;

Palmer, SM ;

Cantu, E ;

Appel, JZ ;

Messier, RH ;

Davis, RD .

TRANSPLANTATION, 2005, 80 (03) :320-325

[3] Long-term outcome of chronic hepatitis B in heart transplant recipients [J].

Wedemeyer, H ;

Pethig, K ;

Wagner, D ;

Flemming, P ;

Oppelt, P ;

Petzold, DR ;

Haverich, A ;

Manns, MP ;

Boeker, KHW .

TRANSPLANTATION, 1998, 66 (10) :1347-1353

← 1 →